Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.03 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Johannes Jacob Pieter Kastelein M.D., Ph.D., FESC

Co-Principal Investigator and Member of The Medical Advisory Board, AtheroNova Inc.
AgeTotal Calculated CompensationThis person is connected to 88 board members in 10 different organizations across 15 different industries.

See Board Relationships
61--

Background*

Prof. Johannes Jacob Pieter Kastelein, also known as John, M.D., Ph.D., FESC, is an Advisor at BioGeneration Ventures B.V. Prof. Kastelein serves as Scientific Advisor of Forbion Capital Partners. He advises Forbion on the cardiovascular and metabolic disease space and presents Forbion with investment opportunities in these fields. He serves as the Medical Director of Dutch National Foundation for the Identification of Familial Hypercholesterolemia, which he founded. ...

Read Full Background

Corporate Headquarters*

2301 Dupont Drive
Irvine, California 92612

United States

Phone: 949-476-1100
Fax: 949-476-1122

Board Members Memberships*

Director

Education*

MD 1980
University of Amsterdam

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AHROQ:US $0.03 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERONOVA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.